aTyr Pharma Inc (LIFE)
1.595
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
1.595
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Shareholders Equity (Quarterly): 90.66M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 90.66M |
| September 30, 2023 | 98.39M |
| June 30, 2023 | 106.24M |
| March 31, 2023 | 109.88M |
| December 31, 2022 | 71.46M |
| September 30, 2022 | 77.18M |
| June 30, 2022 | 86.64M |
| March 31, 2022 | 98.55M |
| December 31, 2021 | 109.30M |
| September 30, 2021 | 117.61M |
| June 30, 2021 | 40.98M |
| March 31, 2021 | 49.70M |
| December 31, 2020 | 31.65M |
| September 30, 2020 | 32.16M |
| June 30, 2020 | 36.10M |
| March 31, 2020 | 42.13M |
| December 31, 2019 | 21.19M |
| September 30, 2019 | 26.74M |
| June 30, 2019 | 30.23M |
| Date | Value |
|---|---|
| March 31, 2019 | 29.48M |
| December 31, 2018 | 33.65M |
| September 30, 2018 | 38.99M |
| June 30, 2018 | 45.38M |
| March 31, 2018 | 54.50M |
| December 31, 2017 | 64.24M |
| September 30, 2017 | 72.29M |
| June 30, 2017 | 40.03M |
| March 31, 2017 | 50.71M |
| December 31, 2016 | 62.80M |
| September 30, 2016 | 73.99M |
| June 30, 2016 | 86.57M |
| March 31, 2016 | 100.43M |
| December 31, 2015 | 115.05M |
| September 30, 2015 | 129.16M |
| June 30, 2015 | 139.34M |
| March 31, 2015 | -98.01M |
| December 31, 2014 | -91.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
21.19M
Minimum
Dec 2019
117.61M
Maximum
Sep 2021
67.20M
Average
71.46M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Vaxart Inc | 57.80M |
| Allogene Therapeutics Inc | 512.23M |
| AIM ImmunoTech Inc | 10.23M |
| Protalix BioTherapeutics Inc | 33.57M |
| Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 120.65M |
| Total Liabilities (Quarterly) | 30.18M |